Costochondritis & Tietze Syndrome

History:

Costochondritis - anterior chest wall pain at multiple costochondral junctions (typically 2nd-5th), reproducible on palpation, worse on deep inspiration, coughing, or upper-body movement. Can mimic cardiac pain. Often follows URTI, new training load, or trauma.

Tietze syndrome - pain plus visible firm swelling at a single upper costochondral junction (usually 2nd or 3rd) in younger adults. Often post-URTI or strain.

Examination:

Systematic palpation of costochondral and costosternal junctions (2nd-7th); reproducible tenderness is the key positive. Multiple tender adjacent junctions with no swelling = costochondritis. A single visibly swollen, firm, tender junction = Tietze. Cardiorespiratory examination must be normal before accepting a chest-wall diagnosis.

Red flags - exclude before accepting:

Cardiac chest pain (CG95/NG185), pulmonary embolism (NG158), pneumothorax, aortic dissection, pneumonia, chest wall mass with red-flag features (NG12), rib fracture, herpes zoster (rash may lag pain by days).

Costochondritis is a clinical diagnosis. No investigations are required for a typical presentation; investigations are directed at excluding serious causes when concern exists.

• •ECG and troponin if cardiac pain is considered (NICE NG185)

• •Chest X-ray for suspected pneumothorax, pneumonia, rib fracture, or chest wall mass

• •D-dimer or CTPA if PE suspected (NICE NG158)

• •Bloods: not routine. ESR or CRP if inflammatory cause suspected. Vitamin D in persistent or atypical cases

• •Imaging of the costochondral junctions: USS can confirm Tietze swelling. CT for a persistent enlarging chest wall mass to exclude chondrosarcoma.

Both conditions are self-limiting in most cases. Management is conservative.

Reassurance is the most important step. Many patients present with significant cardiac anxiety; once serious causes are excluded, clear reassurance about the benign self-limiting course is therapeutic in itself.

Pharmacological:

• •Topical NSAIDs first-line; efficacy may be limited for deeper joints but worth a trial

• •Short-course oral NSAIDs if topical insufficient (lowest effective dose, gastroprotection if needed)

• •Paracetamol as adjunct; heat or ice for symptomatic relief

• •Avoid strong opioids - inappropriate for self-limiting MSK pain

Address precipitating factors: treat underlying cough, modify provocative activities, address postural factors and training load.

Refractory cases: USS-guided corticosteroid injection is a specialist option - USS is strongly recommended due to pneumothorax risk from pleural proximity. Tietze swelling can outlast the pain by months.

Referral: to MSK or rheumatology if refractory or inflammatory cause suspected. Inflammatory back pain or morning stiffness over 30 minutes raises spondyloarthropathy. Refer urgently for a persistent or enlarging chest wall mass (NICE NG12).

Costochondritis and Tietze syndrome do not require formal structured rehabilitation. Management is primarily conservative; the items below are for recurrent or athletic cases where postural and biomechanical factors contribute.

Phase 1 - Symptom management:

• •Reassurance, topical NSAIDs, oral NSAIDs if needed, heat or ice.

• •Avoid pain-provoking activities; maintain general fitness with non-provocative exercise.

Phase 2 - Recovery and reconditioning:

• •Thoracic mobility: extension over a foam roller, seated rotation, cat-cow stretches.

• •Address thoracic kyphosis and postural stiffness.

• •Pectoral stretching (doorway, corner stretch).

• •Scapular strengthening (retraction, rows, lower trapezius activation).

• •Deep breathing and core stabilisation.

Phase 3 - Return to activity:

• •Gradual return to upper-body exercise.

• •Reintroduce overhead work, pushing, pulling, and sport-specific movements progressively.

• •For athletes: graded return to rowing, weightlifting, swimming, contact sport once pain-free.

For recurrent cases: maintenance thoracic mobility, postural exercises, upper-back and scapular stabiliser strengthening. Identify and address recurrent triggers.

• •NICE CG95: Recent-onset chest pain - The framework for evaluating new chest pain in primary care; rule out cardiac causes before accepting a chest-wall diagnosis.

• •NICE NG185: Acute coronary syndromes - Diagnostic and management pathway when ACS is considered, including troponin protocols.

• •NICE NG158: Venous thromboembolic diseases - Wells score and CTPA pathway for suspected pulmonary embolism.

• •NICE NG12: Suspected cancer recognition and referral - Persistent or enlarging chest wall mass requires investigation to exclude chondrosarcoma.

• •Evidence base is sparse; reassurance and topical NSAIDs are widely supported but not RCT-validated.

• •Costochondritis: tenderness at MULTIPLE costochondral junctions (2nd-5th), no visible swelling, female-predominant over 40. Tietze: a SINGLE visibly swollen junction in younger adults. Swelling is the key distinction.

• •Both are diagnoses of exclusion. Always rule out cardiac (CG95/NG185), PE (NG158), and other serious causes first.

• •Reproducible tenderness on palpation is the key positive finding - interpret in the full clinical context.

• •Reassurance is the most important management step. Topical NSAIDs first-line; no role for strong opioids.

• •USS-guided corticosteroid injection is a specialist option for refractory cases. USS is required to avoid iatrogenic pneumothorax.

• •Persistent or enlarging chest wall mass requires imaging to exclude chondrosarcoma (NG12). Herpes zoster pain may precede the rash by days.